Amgen (AMGN) PT Lowered to $340 at Cantor Fitzgerald

February 5, 2025 10:03 AM EST Send to a Friend
Cantor Fitzgerald analyst Olivia Brayer lowered the price target on Amgen (NASDAQ: AMGN) to $340.00 (from $405.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login